All Stories

  1. Esophageal microbiome signature in patients with Barrett’s esophagus and esophageal adenocarcinoma

    Article • PLoS ONE, May 2020, PLOS

    Giovanni Cammarota

  2. Lung and Gut Microbiota as Potential Hidden Driver of Immunotherapy Efficacy in Lung Cancer

    Article • Mediators of Inflammation, November 2019, Hindawi Publishing Corporation

    Giovanni Cammarota

  3. Guidelines - Stool banking for faecal microbiota transplantation in clinical practice

    Article • Gut, September 2019, BMJ

    Giovanni Cammarota, Dr Benjamin Mullish

  4. Emerging drugs for the treatment of clostridium difficile

    Article • Expert Opinion on Emerging Drugs, January 2019, Taylor & Francis

    Giovanni Cammarota

  5. Response to: Comment on “Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease”

    Article • Mediators of Inflammation, August 2018, Hindawi Publishing Corporation

    Giovanni Cammarota

  6. Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions

    Article • Alimentary Pharmacology & Therapeutics, May 2018, Wiley

    Giovanni Cammarota

  7. Gut Microbiota as a Driver of Inflammation in Nonalcoholic Fatty Liver Disease

    Article • Mediators of Inflammation, January 2018, Hindawi Publishing Corporation

    Giovanni Cammarota

  8. Endoscopic evaluation of celiac disease

    Article • Endoscopy International Open, April 2016, Thieme Publishing Group

    Giovanni Cammarota